Quarterly report · Q2

Period2023-01-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥28.3bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥48.7bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥24.5bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income¥8.2bn2023-01-01 → 2023-06-30Cons.Operating income
Operating income¥8.1bn2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income¥11.2bn2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥17.6bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.5bn2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥11.1bn2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥9.5bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥8.1bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥12.5bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.8bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥8.1bn2023-01-01 → 2023-06-30Cons.Profit loss
Net income¥6.8bn2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥111.6bnat 2023-06-30Cons.Assets
Total assets¥102.2bnat 2022-12-31Cons.Assets
Total assets¥98.9bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥12.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥11.1bnat 2022-12-31Cons.Liabilities
Net assets / equity¥99.5bnat 2023-06-30Cons.Net assets
Net assets / equity¥91.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥89.2bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥40.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥35.0bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥35.0bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥31.6bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥33.9bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥34.9bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow¥4.1bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥7.8bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.8bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.3bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥6.3bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.4bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥946m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥6.1bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.8bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥95.282023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥56.462023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥145.482022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.522022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.022022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥94.972023-01-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥145.112022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥78.332022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio88.9%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥2.6bn
jpcrp040300-q2r_E02331-000Dental Productsreportable segmentrevenue2023-01-01 → 2023-06-30¥22.4bn
jpcrp040300-q2r_E02331-000Dental Productsreportable segmentrevenue external2023-01-01 → 2023-06-30¥22.4bn
jpcrp040300-q2r_E02331-000Dental Productsreportable segmentsegment profit2023-01-01 → 2023-06-30¥9.1bn
jpcrp040300-q2r_E02331-000Industrial Productsreportable segmentrevenue2023-01-01 → 2023-06-30¥4.0bn
jpcrp040300-q2r_E02331-000Industrial Productsreportable segmentrevenue external2023-01-01 → 2023-06-30¥4.0bn
jpcrp040300-q2r_E02331-000Industrial Productsreportable segmentsegment profit2023-01-01 → 2023-06-30¥879m
jpcrp040300-q2r_E02331-000Surgical Productsreportable segmentrevenue2023-01-01 → 2023-06-30¥1.8bn
jpcrp040300-q2r_E02331-000Surgical Productsreportable segmentrevenue external2023-01-01 → 2023-06-30¥1.8bn
jpcrp040300-q2r_E02331-000Surgical Productsreportable segmentsegment profit2023-01-01 → 2023-06-30¥889m
—segment totalrevenue2023-01-01 → 2023-06-30¥28.3bn
—segment totalrevenue external2023-01-01 → 2023-06-30¥28.3bn
—segment totalsegment profit2023-01-01 → 2023-06-30¥10.8bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥2.2bn
jpcrp040300-q2r_E02331-000Dental Productsreportable segmentrevenue2022-01-01 → 2022-06-30¥20.5bn
jpcrp040300-q2r_E02331-000Dental Productsreportable segmentrevenue external2022-01-01 → 2022-06-30¥20.5bn
jpcrp040300-q2r_E02331-000Dental Productsreportable segmentsegment profit2022-01-01 → 2022-06-30¥8.7bn
jpcrp040300-q2r_E02331-000Industrial Productsreportable segmentrevenue2022-01-01 → 2022-06-30¥2.3bn
jpcrp040300-q2r_E02331-000Industrial Productsreportable segmentrevenue external2022-01-01 → 2022-06-30¥2.3bn
jpcrp040300-q2r_E02331-000Industrial Productsreportable segmentsegment profit2022-01-01 → 2022-06-30¥774m
jpcrp040300-q2r_E02331-000Surgical Productsreportable segmentrevenue2022-01-01 → 2022-06-30¥1.7bn
jpcrp040300-q2r_E02331-000Surgical Productsreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.7bn
jpcrp040300-q2r_E02331-000Surgical Productsreportable segmentsegment profit2022-01-01 → 2022-06-30¥885m
—segment totalrevenue2022-01-01 → 2022-06-30¥24.5bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥24.5bn
—segment totalsegment profit2022-01-01 → 2022-06-30¥10.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 542
ItemContextValueUnit
Payments into time deposits inv cfPrior1YTDDuration-3006312000JPY
Payments into time deposits inv cfCurrentYTDDuration-2170698000JPY
Proceeds from withdrawal of time deposits inv cfPrior1YTDDuration2167067000JPY
Proceeds from withdrawal of time deposits inv cfCurrentYTDDuration493500000JPY
Purchase of insurance funds inv cfPrior1YTDDuration-6741000JPY
Purchase of insurance funds inv cfCurrentYTDDuration-7213000JPY
Proceeds from cancellation of insurance funds inv cfPrior1YTDDuration-JPY
Proceeds from cancellation of insurance funds inv cfCurrentYTDDuration110352000JPY
Proceeds from cancellation of money held in trust inv cfPrior1YTDDuration-JPY
Proceeds from cancellation of money held in trust inv cfCurrentYTDDuration2093108000JPY
Other net inv cfPrior1YTDDuration3838000JPY
Other net inv cfCurrentYTDDuration-493000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-3363793000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-2290437000JPY
Increase in short term loans payable fin cfPrior1YTDDuration-JPY
Increase in short term loans payable fin cfCurrentYTDDuration2000000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-402688000JPY
Cash dividends paid fin cfPrior1YTDDuration-1722570000JPY
Cash dividends paid fin cfCurrentYTDDuration-2043463000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-1077655000JPY
Purchase of treasury stock fin cfCurrentYTDDuration-499914000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-2800225000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-946067000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration2365212000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration2408310000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-993595000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration3274767000JPY
Cash and cash equivalentsPrior2YearInstant34887816000JPY
Cash and cash equivalentsPrior1YearInstant31648571000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary ccePrior1YTDDuration-JPY
Increase in cash and cash equivalents from newly consolidated subsidiary cceCurrentYTDDuration82767000JPY
Cash and cash equivalentsPrior1QuarterInstant33894220000JPY
Cash and cash equivalentsCurrentQuarterInstant35006105000JPY
Salaries and allowances sgaPrior1YTDDuration2254096000JPY
Salaries and allowances sgaCurrentYTDDuration3101912000JPY
Retirement benefit expenses sgaPrior1YTDDuration79072000JPY
Retirement benefit expenses sgaCurrentYTDDuration108487000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember20530662000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember1681197000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember2250354000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember24462214000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration24462214000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-JPY
Transactions with other segmentsPrior1YTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass